BB Biotech AG 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 5:18 pm Purchase | 2020-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BB Biotech AG | 3,538,419 4.400% | 80,000 (+2.31%) | Filing |
| 2020-02-06 2:29 pm Purchase | 2020-01-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | BB Biotech AG | 3,458,419 5.300% | 1,258,419 (+57.20%) | Filing |